Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

KRAS inhibitor

DRUG CLASS:

KRAS inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

KRAS G12C	Solid Tumor	KRAS G12C	Solid Tumor	MRTX1257 + IN10018 Sensitive: C3 – Early Trials MRTX1257 + IN10018 Sensitive : C3	MRTX1257 + IN10018 Sensitive: C3 – Early Trials MRTX1257 + IN10018 Sensitive : C3
KRAS mutation	Lung Adenocarcinoma	KRAS mutation	Lung Adenocarcinoma	KRAS inhibitor Resistant: C3 – Early Trials KRAS inhibitor Resistant : C3	KRAS inhibitor Resistant: C3 – Early Trials KRAS inhibitor Resistant : C3
KRAS G12C + ATM wild-type	Non Small Cell Lung Cancer	KRAS G12C + ATM wild-type	Non Small Cell Lung Cancer	KRAS inhibitor Resistant: C3 – Early Trials KRAS inhibitor Resistant : C3	KRAS inhibitor Resistant: C3 – Early Trials KRAS inhibitor Resistant : C3
KRAS G12C + SMARCA4 wild-type	Non Small Cell Lung Cancer	KRAS G12C + SMARCA4 wild-type	Non Small Cell Lung Cancer	KRAS inhibitor Sensitive: C3 – Early Trials KRAS inhibitor Sensitive : C3	KRAS inhibitor Sensitive: C3 – Early Trials KRAS inhibitor Sensitive : C3
KRAS mutation	Multiple Myeloma	KRAS mutation	Multiple Myeloma	AZD4785 Sensitive: D – Preclinical AZD4785 Sensitive : D	AZD4785 Sensitive: D – Preclinical AZD4785 Sensitive : D
KRAS G12C	Non Small Cell Lung Cancer	KRAS G12C	Non Small Cell Lung Cancer	selinexor + MRTX1257 Sensitive: D – Preclinical selinexor + MRTX1257 Sensitive : D	selinexor + MRTX1257 Sensitive: D – Preclinical selinexor + MRTX1257 Sensitive : D
KRAS G12C	Pancreatic Ductal Adenocarcinoma	KRAS G12C	Pancreatic Ductal Adenocarcinoma	selinexor + MRTX1257 Sensitive: D – Preclinical selinexor + MRTX1257 Sensitive : D	selinexor + MRTX1257 Sensitive: D – Preclinical selinexor + MRTX1257 Sensitive : D
KRAS G12V	Solid Tumor	KRAS G12V	Solid Tumor	QTX3034 Sensitive: D – Preclinical QTX3034 Sensitive : D	QTX3034 Sensitive: D – Preclinical QTX3034 Sensitive : D
KRAS G12C	Multiple Myeloma	KRAS G12C	Multiple Myeloma	MRTX1257 Sensitive: D – Preclinical MRTX1257 Sensitive : D	MRTX1257 Sensitive: D – Preclinical MRTX1257 Sensitive : D